PreveCeutical Medical Inc (18H) — Financial Flexibility Index
PreveCeutical Medical Inc (18H) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of €-520.46K (operating CF €-520.46K minus capex €0.00) represents 0% of total liabilities (€7.85 Million). Check 18H capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PreveCeutical Medical Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for PreveCeutical Medical Inc across 9 annual periods. For the full cash flow conversion analysis, see PreveCeutical Medical Inc (18H) cash conversion ratio.
Annual Financial Flexibility Index for PreveCeutical Medical Inc (2016–2024)
Year-by-year free cash flow to debt coverage for PreveCeutical Medical Inc. Explore PreveCeutical Medical Inc (18H) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.06x | €-424.89K | €-426.69K | €6.86 Million | ▼ -24.3% |
| 2023 | -0.05x | €-296.97K | €-296.97K | €5.96 Million | ▲ +46.7% |
| 2022 | -0.09x | €-450.99K | €-450.99K | €4.82 Million | ▼ -7.4% |
| 2021 | -0.09x | €-371.19K | €-426.39K | €4.27 Million | ▼ -605.6% |
| 2020 | 0.02x | €67.25K | €64.59K | €3.91 Million | ▲ +109.3% |
| 2019 | -0.19x | €-992.61K | €-993.94K | €5.34 Million | ▲ +89.7% |
| 2018 | -1.81x | €-7.57 Million | €-7.57 Million | €4.19 Million | ▼ -28.7% |
| 2017 | -1.40x | €-4.13 Million | €-4.30 Million | €2.94 Million | ▲ +46.2% |
| 2016 | -2.61x | €-1.31 Million | €-1.32 Million | €503.24K | — |